Jazz Pharmaceuticals (JAZZ) Inventory Average (2011 - 2026)

Jazz Pharmaceuticals' Inventory Average history runs 16 years deep, the most recent figure standing at $427.2 million for Q1 2026.

• In Q1 2026, Inventory Average fell 12.2% year-over-year to $427.2 million; the TTM figure through Mar 2026 stood at $427.2 million (down 12.2% YoY), while the FY2025 annual figure was $448.7 million, down 16.71% from the prior year.
• Inventory Average was $427.2 million for Q1 2026 at Jazz Pharmaceuticals, down from $450.1 million in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $1.0 billion in Q1 2022 to a low of $427.2 million in Q1 2026.
• Historically, Inventory Average has averaged $624.9 million across 5 years, with a median of $587.2 million in 2024.
• Biggest YoY gain for Inventory Average was 876.04% in 2022; the steepest drop was 34.76% in 2022.
• A 5-year view of Inventory Average shows it stood at $721.1 million in 2022, then slipped by 16.18% to $604.4 million in 2023, then slipped by 15.64% to $509.9 million in 2024, then decreased by 11.73% to $450.1 million in 2025, then dropped by 5.07% to $427.2 million in 2026.
• The last three Inventory Average figures came in at $427.2 million (Q1 2026), $450.1 million (Q4 2025), and $494.0 million (Q3 2025), per Business Quant data.